Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity

Heat shock protein (HSP)-based anticancer vaccines have undergone successful preclinical testing and are now entering clinical trial. Questions still remain, however regarding the immunological properties of HSPs. It is now accepted that many of the HSPs participate in tumor immunity, at least in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Calderwood, Stuart K., Murshid, Ayesha, Gong, Jianlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342006/
https://www.ncbi.nlm.nih.gov/pubmed/22566956
http://dx.doi.org/10.3389/fimmu.2012.00075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342006/
https://www.ncbi.nlm.nih.gov/pubmed/22566956
http://dx.doi.org/10.3389/fimmu.2012.00075

Ejemplares similares